These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16257326)

  • 1. The trials of cancer chemoprevention.
    Lancet; 2005 Oct 29-Nov 4; 366(9496):1506. PubMed ID: 16257326
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials. Nail-biting time for trials of COX-2 drugs.
    Couzin J
    Science; 2004 Dec; 306(5702):1673-5. PubMed ID: 15576585
    [No Abstract]   [Full Text] [Related]  

  • 3. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical issues of intervention trials in cancer.
    Sancho-Garnier H; Joseph R
    IARC Sci Publ; 1996; (136):121-2. PubMed ID: 8791122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
    Masmoudi A; Chevalier TL; Sabatier L; Soria JC
    Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K; Akay MT; Abbasoglu O; Ercan A
    Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase inhibition as a target for prevention of tobacco-related cancers.
    Boyle JO
    Clin Cancer Res; 2004 Mar; 10(5):1557-8. PubMed ID: 15014002
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer chemoprevention: additional observations.
    Singh-Ranger G; Mokbel K
    Int J Clin Pract; 2003 Mar; 57(2):155; author reply 155. PubMed ID: 12661805
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
    Harris RE; Alshafie GA; Abou-Issa H; Seibert K
    Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for cancer chemoprevention: still a headache?
    Garber K
    J Natl Cancer Inst; 2004 Feb; 96(4):252-3. PubMed ID: 14970267
    [No Abstract]   [Full Text] [Related]  

  • 12. NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004.
    Goodin S; Shiff SJ
    Clin Cancer Res; 2004 Mar; 10(5):1561-4. PubMed ID: 15014004
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.
    Thompson IM; Basler JA; Leach R; Troyer D; Klein E; Brawley O
    Urol Oncol; 2003; 21(1):73-8. PubMed ID: 12684131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vioxx withdrawal alarms cancer prevention researchers.
    Vanchieri C
    J Natl Cancer Inst; 2004 Dec; 96(23):1734-5. PubMed ID: 15572751
    [No Abstract]   [Full Text] [Related]  

  • 15. On cancer chemoprevention: complications and limitations of some proposed strategies.
    Paolini M; Mesirca R; Gialluca N; Bauer C; Biagi GL; Cantelli-Forti G
    Carcinogenesis; 1995 Apr; 16(4):971-3. PubMed ID: 7728984
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H
    Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention in gastroenterology.
    Hull M; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):443. PubMed ID: 22122761
    [No Abstract]   [Full Text] [Related]  

  • 20. COX-2: a target for colon cancer prevention.
    Marnett LJ; DuBois RN
    Annu Rev Pharmacol Toxicol; 2002; 42():55-80. PubMed ID: 11807164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.